Delivery Order SPE2DB22D3301-SPE2DB24FZ2WG

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,024.99, is a Firm Fixed Price Delivery Order with an ultimate completion date of September 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the specified medication to support military treatment...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The firm fixed-price delivery order, valued at $2,243.89, has an ultimate completion date of September 19, 2024. The award was made on September 18, 2024 and does not have a set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The $1,604.16 firm fixed price delivery order has a completion date of July 18, 2024. It is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various agencies, including an...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The $1,414.56 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a $1,200.61 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The award has an ultimate completion date of August 15, 2022 and was made without any set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award, valued at $3,921.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of September 11, 2024. The contract is not set aside for any specific business category. Amerisourcebergen is a major supplier of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DB22D2007|SPE2DB24FJ2AD) with a firm fixed price of $1,261.57 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,005.20 firm fixed-price delivery order is for the medical product "CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML" and has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.37 Firm Fixed Price Delivery Order contract is for the supply of 4567279733 CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, with a period of performance through February 18, 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a larger $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $8,611.20, is a Firm Fixed Price Delivery Order for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product used in medical treatments. The contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This contract is not designated as a set-aside....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2WG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a Delivery Order valued at $1,747.86 for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 14, 2024. The contract is a Firm Fixed Price type with no set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen frequently receives federal contract awards from the DLA and other agencies to provide a wide range of critical medical supplies and prescription drugs to support military treatment facilities, veterans' hospitals, and other government healthcare programs. The company maintains substantial Indefinite Delivery Contracts with the DLA and Department of Justice to efficiently deliver these essential medical commodities across the federal government.

Generated 11/12/24, 9:07 AM